中国医药导报
中国医药期刊欢迎您 今天是   2025年4月15日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  妇幼医学 本期目录 | 过刊浏览 | 高级检索 |
超重及肥胖对支气管哮喘儿童规范化治疗效果及肺功能的影响
李京鹏1      刘传合2▲      王蒙蒙1      魏红1      王根香1
1.北京市西城区展览路医院儿科,北京   100044;
2.首都儿科研究所附属儿童医院哮喘防治中心与肺功能室,北京   100020
Effects of overweight and obesity on standardized treatment and pulmonary function in children with bronchial asthma
LI Jingpeng1   LIU Chuanhe2▲   WANG Mengmeng1   WEI Hong1   WANG Genxiang1
1.Department of Pediatrics, Zhanlanlu Hospital in Xicheng District, Beijing   100044, China; 
2.Department of Asthma Center and Lung Function Laboratory, Children’s Hospital, Capital Institute of Pediatrics, Beijing   100020, China
全文: PDF (504 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨超重及肥胖对支气管哮喘(以下简称“哮喘”)儿童规范化治疗效果及对肺功能的影响。 方法 选取2020年1月至2021年1月北京市西城区展览路医院儿科门诊120例哮喘急性发作期儿童为研究对象,根据体重指数百分位数值法分为超重肥胖组(≥85%,59例)和正常体重组(16%~<85%,61例)。两组均给予规范化治疗,比较两组临床疗效,比较两组哮喘发作次数、因哮喘发作急诊就诊次数和肺功能水平。 结果 超重肥胖组年发作次数、因哮喘发作急诊就诊次数高于正常体重组,哮喘控制测试量表评分低于正常体重组,差异有统计学意义(P<0.05)。超重肥胖组临床疗效差于正常体重组,差异有统计学意义(P<0.05)。治疗后,正常体重组用力肺活量(FVC)、呼气峰流量(PEF)、第1秒用力呼气容积(FEV1)、FEV1/FVC、用力呼出50%肺活量时的瞬间流量(FEF50)高于治疗前;超重肥胖组FVC、PEF、FEV1、FEV1/FVC高于治疗前,差异有统计学意义(P<0.05)。超重肥胖组治疗前后FEF50比较,差异无统计学意义(P>0.05)。超重及肥胖组FEV1、FEV1/FVC、PEF、FEF50改善率低于正常体重组,差异有统计学意义(P<0.05)。 结论 儿童超重及肥胖与哮喘控制不良相关,超重及肥胖可增加哮喘患儿肺功能损害。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李京鹏1 刘传合2▲ 王蒙蒙1 魏红1 王根香1
关键词 肺功能支气管哮喘肥胖儿童
    
Abstract:Objective To investigate the effects of overweight and obesity on standardized treatment and pulmonary function in children with bronchial asthma (“asthma” for short). Methods A total of 120 children with acute asthma attack from January 2020 to January 2021 in the Department of Pediatric Outpatient, Zhanlanlu Hospital in Xicheng District, Beijing were selected as the research objects. According to the body mass index percentile numerical method, they were divided into overweight and obesity group (≥85%, 59 cases) and normal weight group (16%-<85%, 61 cases). Both groups received standardized treatment, the clinical efficacy of two groups was compared; the number of asthma attacks, emergency department visits due to asthma attacks, and lung function level were compared between two groups. Results The number of annual attacks and emergency department visits due to asthma attacks in overweight and obesity group was higher than those in normal weight group, and the score of asthma control test was lower than that in normal weight group, and the differences were statistically significant (P<0.05). The clinical effect of overweight and obesity group was worse than that of normal weight group, and the difference was statistically significant (P<0.05). After treatment, forced vital capacity (FVC), peak expiratory flow (PEF), forced expiratory volume in one second (FEV1), FEV1/FVC, and forced expiratory flow at 50% forced vital capacity (FEF50) in normal weight group were higher than those before treatment; FVC, PEF, FEV1, and FEV1/FVC in overweight and obese group were higher than those before treatment, and the differences were statistically significant (P<0.05). There was no significant difference in FEF50 between overweight and obese groups before and after treatment (P>0.05). The improvement rates of FEV1, FEV1/FVC, PEF, and FEF50 in overweight and obese groups were lower than those in normal weight group, and the differences were statistically significant (P<0.05). Conclusion Overweight and obesity in children are associated with poor asthma control and can increase lung function impairment in children with asthma.
Key wordsLung function    Bronchial asthma    Obesity    Children
    
基金资助:北京市医院管理局重点医学专业发展计划项目(ZYLX201829)。
通讯作者: ▲通讯作者   
引用本文:   
李京鹏1 刘传合2▲ 王蒙蒙1 魏红1 王根香1. 超重及肥胖对支气管哮喘儿童规范化治疗效果及肺功能的影响[J]. 中国医药导报, 2023, 20(6): 108-111.
LI Jingpeng1 LIU Chuanhe2▲ WANG Mengmeng1 WEI Hong1 WANG Genxiang1. Effects of overweight and obesity on standardized treatment and pulmonary function in children with bronchial asthma. 中国医药导报, 2023, 20(6): 108-111.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.06.24     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I6/108

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司